Ambrosia Biosciences Inc.
Boulder, US · Founded 2024 · Delaware corporation · 2 known investors
Founders & leadership
NT
Nicholas TraggisExecutive
Board
KL
DS
David SnitmanBoard director
WS
William S. MarshallBoard director
JO
John OrwinBoard director
Investors · 2
Funding
SEC filings, press & company announcements$16M disclosed across 1 of 2 rounds · 2024–2026
- Undisclosed amountSeries BMar 2026Source ↗
▶$16MraisedAug 2024 · 7 investors · BiotechnologyRule 506(b)
▶$16MraisedAug 2024 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David SnitmanDirector
- William S. MarshallDirector
- Nicholas TraggisExecutive Officer, Director
- Kyle LefkoffDirector
- John OrwinDirector
- Offering amount
- $25M
- Amount sold
- $16M
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Ambrosia Biosciences Inc.'s investors?
- Ambrosia Biosciences Inc.'s investors include Biotechnology Value Fund, Boulder Ventures.
- How much funding has Ambrosia Biosciences Inc. raised?
- Ambrosia Biosciences Inc. has disclosed $16M raised across 1 of its 2 known rounds.
- Where is Ambrosia Biosciences Inc. headquartered?
- Ambrosia Biosciences Inc. is headquartered in Boulder, US.